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Prognostic value and importance of surgery combined
with postoperative radiotherapy for oral and oropharyngeal cancer
Adam Maciejewski
A i m s.  The aim of this paper is to evaluate the efficacy of surgery for patients with oral cavity or oropharyngeal cancer, and
is impact on the final results of treatment combined with postoperative radiotherapy. Furthermore, predictive and prognostic
value of clinical and histopatological postoperative factors were analysed, and estimation of clinical applicability of modified
scale for risk of postoperative local and/or nodal recurrence according to Peters was checked.
M a t e r i a l  a n d  m e t h o d s.  Material includes 218 cases of the advanced oral cavity or oropharyngeal cancer All data
were subdivided into 4 groups depending on treatment strategy. For the analysis of the treatment efficacy (overall and
disease-free survival) many predictive and prognostic factors have been considered. Despite of multivariate logistic regres-
sion analysis of these factors, the risk of local recurrence was related to the results of combined treatment based on the mo-
dified numerical risk scale adapted from Peters. The risk value is the sum of scores given to individual prognostic factors.
Time interval between surgery and radiotherapy (TI) and overall treatment time (TTT) have been accounted for the
analysis.
R e s u l t s. Generally, optimal results were noted in the group B, where surgery has been combined with postoperative radio-
therapy. In case of surgery combined with preoperative radiotherapy (group E) 5-year DFS was 30%, and in the case when ra-
diotherapy was delayed and applied when recurrence after primary surgery has occurred, the 5-year DFS was not higher than
20%. Macro- and microscopic surgical radicalism has been found one of the most important and significant prognostic fac-
tors. For positive margins (m+) 5-year DFS significantly decreases to about 20%. Surgical macro- and microradicalism has
an important impact (p=0.013) on the incidence of distant metastases. The scoring system for the recurrence was based on
Peters scale. The sum of the risk scores (TRRl+n) for individual prognostic factors allow to allocate clinical data into four risk
groups. Increase of TRRl+n by one point correlates with the decrease in 5-year DFS by about 3%. The TRRl+n factor has be-
en found the most powerful and independent prognostic and predictive factor.
C o n c l u s i o n s. 1. For patients with oral cavity or pharyngeal cancer, macro- and microscopically radical surgery is an effec-
tive treatment if combined with radiotherapy, and it provides a high probability of 5-year disease free survival and decreases
the risk of distant metastases. 2. Presence and semi-quantitative value of well known clinical, surgical and pathological
prognostic factors can be counted as a single numerical index of local failure, according to the modified Peters scale. The
TRRl+n index is the most powerful, significant and independent predictor and prognostic factor.
Ocena wartoÊci prognostycznej leczenia operacyjnego
i jego miejsca w leczeniu skojarzonym z radioterapià
u chorych na raka jamy ustnej i gard∏a
C e l. 1. Ocena skutecznoÊci leczenia operacyjnego chorych na raka jamy ustnej lub gard∏a i jej wp∏ywu na ∏àczne wyniki le-
czenia skojarzonego z pooperacyjnà radioterapià. 2. Zbadanie wartoÊci predykcyjnej i prognostycznej klinicznych i histologicz-
nych czynników pooperacyjnych oraz przydatnoÊci klinicznej zmodyfikowanej skali ryzyka wznowy.
M a t e r i a ∏  i m e t o d y k a. Materia∏ obejmuje grup´ 218 chorych na raka jamy ustnej lub gard∏a. Materia∏ podzielono na 4
grupy w zale˝noÊci od taktyki leczenia. Oprócz wieloparametrowej analizy regresji logitowej licznych czynników progno-
stycznych i predykcyjnych, ryzyko wznowy okreÊlano w oparciu o zmodyfikowanà punktowà skal´ ryzyka wg Petersa. W ana-
lizie uwzgl´dniono znaczenie prognostyczne czasu przerwy mi´dzy leczeniem operacyjnym i radioterapià (TI) oraz ca∏kowite-
go czasu skojarzonego leczenia.
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Introduction
Cancers of head and neck belong to the group of the
most clinically and histologically heterogeneous tumo-
urs, and thus optimal treatment strategy is still widely di-
scussed. The use of specific treatment modality is usually
based on well recognised prognostic criteria, i.e., tumour
histology, grade and stage. The choice of surgery and/or
radiotherapy is crucial, because the first therapeutic deci-
sion is critical for treatment outcome [1-4].
There is an increasing interest on tumour biology
and kinetics of growth to define a new prognostic factors
which could be useful predictors for optimal treatment
schedules and its sequence [5]. It seems urgent to establi-
shed significant power and hierarchy of prognostic factors
and parameters gathered during and as the result of first
treatment method which could be used as a guideline for
the optimal choice of the second one, if combined treat-
ment is planned.
In combined treatment it is an important obligation
for surgeon to consider many numerical and rank factors in
order to ensure radical effect of surgical treatment. In 1993
Peters et al. [6, 7] have set up in order the most impor-
tant prognostic factors, and they proposed a rank scale for
local and nodal recurrence risk as a basic rationale criteria
for postoperative radiotherapy. There are only a few and
fragmentary studies in this field, and its mainly concentra-
te on a single prognostic factor [7-10]. This situation moti-
vates the present study, which the aim is to evaluate the
efficacy of surgery of oral cavity and oropharyngeal can-
cers and to analyse its impact on overall results of treat-
ment combined with postoperative radiotherapy. An im-
portant point of interest is to establish clinical applicability
of the Peters` rank system for the risk of locoregional re-
currence.
Material and methods
The group of 218 consequentive patients with oral cavity and
oropharyngeal cancer treated with surgery in the Institute Of
Oncology in Gliwice in 1986-1991 were included into the study.
There were 75 females and thus male to female ratio was 3:1. Pa-
tient`s age was in the range of 27-83 years, and the average was
54 years. Primary tongue cancer was in 30% of cases, tonsil can-
cer in 27%, oral cancer was in 30% of cases and other localisa-
tion in 27%. All three levels of pharynx were involved in 30 cases
(14%). In 82% of cases it was squamous cell cancer, in 8%
transitional cell cancer, in 5% anaplastic cancer and in 4% ade-
nocarcioma. In two cases malignant tumour was diagnosed, ho-
wever histological type has not been established. Histological
grade has been defined in 176 cases (81%), G I in 63%, G II in
13,5% and G III in 4,5% of cases. Patient`s characteristic in
relation to TNM stage is presented in Table I.
Tab. I. Characteristics of the TNM stage
Stage Number pts. %
(TNM)
T1-2 N0-1 130 60
T3-4 N0-1 38 17
T1-2 N2-3 28 13
T3-4 N2-3 14 6
TX N0-3 6 3
TX NX 3 1
Tr e a t m e n t  m e t h o d s
All cases were subdivided into 5 subgroups according to the
methods of treatment:
(A) surgery alone – 8 cases (4%); (B) surgery with posto-
perative radiotherapy – 143 cases (66%); (C, D) surgery with de-
layed radiotherapy for postoperative local recurrence with or
without salvage surgery – 20cases (9%) and (E) surgery with
preoperative radiotherapy – 47 cases (21%). Macroscopically
radical surgery was performed in 131 cases (60%), non radical
was in 45 cases (21%) and in the remaining 42 cases (19%)surgi-
cal radicalism was not clearly documented. Neck nodes exci-
sion was performed in 111 cases and it was radical in 57% of
them.
Radiotherapy was delivered using gamma 60 Co or 6-10
MeV photons. Total dose of 50-70 Gy (64% of them received to-
tal dose in the range of 65-70 Gy) was conventionally fractiona-
ted with one daily fraction of 2.0-2.5 Gy in overall treatment ti-
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W y n i k i. Generalnie najkorzystniejsze wyniki uzyskano w Gr. B, w której leczenie chirurgiczne uzupe∏nia∏a pooperacyjna ra-
dioterapia. W przypadku radioterapii, poprzedzajàcej leczenie operacyjne (Gr. E), 5-letnie DFS wynosi∏o 30%, a w sytuacji,
gdy RT stosowano dopiero po wystàpieniu wznowy pooperacyjnej (Gr. C i D), 5-letnie DFS nie przekracza∏o 20%. Jednym
z najbardziej istotnych czynników prognostycznych okaza∏a si´ makro- i mikroskopowa radykalnoÊç leczenia operacyjnego.
Chirurgiczna radykalnoÊç makro- i mikroskopowa mia∏a znamienny wp∏yw na cz´stoÊç przerzutów odleg∏ych. W badaniach
w∏asnych pos∏u˝ono si´ zmodyfikowanà punktowà skalà ryzyka wznowy wg Petersa. Suma punktów ryzyka pRWm+w decy-
dowa∏a o uporzàdkowaniu materia∏u w 4 grupy wed∏ug osiàgni´tego ryzyka niepowodzenia. Wzrost pRWm+w o 1 punkt wià-
za∏ si´ z obni˝eniem szansy 5-letniego prze˝ycia bezobjawowego Êrednio o oko∏o 3%. Wskaênik pRWm+w okaza∏ si´ najsil-
niejszym i niezale˝nym czynnikiem prognostycznym. Oprócz tego czynnika, równie˝ czas przerwy mi´dzy operacjà i uzupe∏nia-
jàcà radioterapià (TI) okaza∏ si´ silnym i znamiennym czynnikiem prognostycznym.
W n i o s k i. U chorych na zaawansowanego raka jamy ustnej lub gard∏a radykalne makro- i mikroskopowo leczenie operacyjne
jest skutecznym elementem taktyki leczenia skojarzonego, obcià˝onej niskim ryzykiem powik∏aƒ i stwarza wysokà szans´ 5-let-
niego prze˝ycia bezobjawowego oraz obni˝a ryzyko wystàpienia przerzutów odleg∏ych. ObecnoÊç i pó∏iloÊciowy udzia∏ uznanych
czynników klinicznych, operacyjnych i histopatologicznych mo˝na wyraziç w formie wskaênika ryzyka wznowy wg zmodyfikowa-
nej skali Petersa. Wskaênik ten wykazuje najsilniejszà, samodzielnà i znamiennà wartoÊç predykcyjnà i prognostycznà.
Key words: wartoÊç predykcyjna i prognostyczna, punktowa skala ryzyka, suma punktów ryzyka
S∏owa kluczowe: predictive and prognostic value, numerical risk scale, the sum of risk scores
me (OTT) of 4-7 weeks. Time interval between surgery and ra-
diotherapy (TI) was not longer than 7 weeks only in 33% of ca-
ses, in 42% TI was 8-14 weeks. Total combined treatment time
(TTT = OTT + TI + 1) was also introduced as a prognostic fac-
tor, and in 36% of cases it was shorter than 14 weeks, in 47% it
was in the range of 15-25 weeks and in the remaining TTT was
longer than 25 weeks.
Rank scoring system for loco-regional risk was proposed by
Peters et al. in 1993. It was modified and adapted for the present
analysis. This system includes two risk scales, one for local recur-
rence (Tab. II) and the second for nodal recurrence (Tab. III).
The first one (RRl), with the range of 0-12 risk points, includes
macro- and microscopic margins, its width, vessel invasion and
tumour grading. The second one (RRn) with the range of 0-9
risk points takes into account number of positive nodes related
to the number of excised nodes, type of excision, extracapsular
invasion and grading. This system was modified by giving hi-
gher points to positive macroscopic margins and to extracapsu-
lar invasion. Moreover, total risk score (TRRl+n) has been in-
troduced, which is the sum of RRl and RRn being in the range
of 0-21 points.
Tab. II. Modified rank scale for local recurrence
[according to Peters, 6, 7]
Risk factors Characteristics Scale
Macroscopic (-) 0
Margin one or more (+) 3
Histopatological (-) 0
Margin one (+) 2
>one or unknown (+) 3
Margin width >5 mm 0
<5 mm or unknown 2
Vessel invasion (-) 0
(+) 2
Histological grade 1-2 0
3 2
Tab. III. Modified rank scale for nodal recurrence
[according to Peters, 6, 7]
Risk factors Characteristic Scale
No. of metastatic nodes crille excision – 1 (+) / > 10 1
crille excision – 1 (+) / < 10 2
1 (+) – no. of excised nodes
unknown 2
selective
lymphadenectomy
1 (+) 2
> 1 (+) 3
Extracapsular invasion (-) 0
(+) 3
Histological grade 1-2 0
3 3
Results
In the group of 218 cases overall 5-year actuarial dise-
ase-free survival of 35% has been noted. There was signi-
ficant correlation between T stage and 5-year DFS. The
increase from T1 to T4 stage corresponded with decre-
asing of 5-year DFS from 70% to 25%. Nodal stage incre-
asing from N0 to N3 also resulted in 28% decrease in 5-
-year DFS, however this tendency was no statistically si-
gnificant. Generally, an increase in T (T1 – T4) and
N (N0 – N3) stage leads to 3-fold decrement in DFS.
In the group B, C and D including all together 163
cases (75%), surgery was the primary but not the only
treatment modality. Actuarial 5-year DFS was significan-
tly higher when surgery was combined with radiotherapy
(B), than in cases (C, D) in which RT was delayed until lo-
cal recurrence occurred (20%). For the group E with pre-
operative RT 5-year DFS was not higher than 30%.
The results show that macroscopically radical surge-
ry produces on average 44% 5-year DFS (Fig. 1), which
is significantly 2 times higher than the results of non
radical surgery (21% 5-year DFS). Similar tendency
was noted for histologically negative margins (Fig. 2)
as compared with positive margins (55% vs. 32% 5-year
DFS). This difference was highly significant (p=0.005).
Also interval between surgery and radiotherapy (TI)
and total combined treatment time (TTT) showed si-
gnificant power as prognostic factors (p=0.01 and
p=0.009). The longer TI or TTT the lower 5-year DFS
has been noted. This reverse correlation was the most
evident for cases with postoperative microscopically ne-
gative margins.
Overall failure rate was 50% (108 of 218 cases) inc-
luding 26% of local and 11% of nodal recurrences.
Among 19% of distant metastases, 7% developed toge-
ther with local recurrence (Tab. IV). In group E with
preoperative radiotherapy the incidence of loco-regio-
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Fig. 1. Actuarial disease-free survival (DFS) depending on macroscopi-
cal results of surgery
Fig. 2. Actuarial disease-free survival (DFS) depending on surgical
margins histology
nal recurrences and distant metastases was about 2-3 ti-
mes higher than in group B with postoperative RT
(p=0.0001). When the RT was delayed until local recur-
rence occurred after surgery as primary treatment (group
C, D) the incidence of all types of failure was higher
than in the group B.
Interesting impact of radical surgery on distant meta-
stases – free survival was noted (Fig. 3). Macro- and mi-
croscopically radical surgery combined with postopera-
tive RT provides 5-year distant meta-free survival 20%
higher (p=0.01) than in case of non radical surgery (72%
vs. 52%).
Multivariate regression analysis shows highly signifi-
cant and independent prognostic power for the total sco-
re for loco-regional recurrence risk.
For practical reason scores were subdivided into two
main groups – low risk with TRRl+n (<10 points) and
high risk with TRRl+n (>10 points). An increase of
TRRl+n from less than 4 points to more than 10 points
generally caused (a) a significant and dramatic decrease in
5-year DFS from 62%, (b) an increase of locoregional
recurrence risk from 28% to 41% and (c) 2-fold increase
of distant metastases risk from 10% to 21% (Tab. V).
Generally, surgical and histological risk factors which
cause the increase of TRRl+n from less than 4 points to
more than 10 points significantly correlate with 2-fold hi-
gher risk of single or more failure types.
Figure 5 shows that with the increasing TRRl+n
from 1 to >15 points 5-year DFS decreases from 58%
to 18% what gives about 3% decrease in the DFS per
one point increase in the TRRl+n. The best prognosis
(75% 5-year DFS) can be expected for TRRl+n not hi-
gher than 4 points and surgery – radiotherapy interval
(TI) shorter than 10 days. For TRRl+n above 15 points
and TI extended to 60 days the 5-years DFS decreases by
about 50% (to 27%).
Discussion
Squamous cell cancers of head and neck represent one
of the most clinically and histologically heterogeneous
group of tumours. Even within the same histologic type,
stage and grade there is a large heterogeneity with re-
spect to tumour biology, kinetics of growth and the risk of
dissemination to regional nodes and tissues. For early
stages (T1-2 N0) surgery is still primary choice of highly
effective treatment strategy. In combination with brachy-
therapy 90% long-term local control can be achieved
[4, 11].
Large group of advanced tumours (T3-4 N0 and T1-
-4 N2-3) is the main candidate to combined treatment.
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Figure 3. Actuarial distant metastases-free survival depending on sur-
gical outcome
Tab. V. Loco-regional control depending on value of total recurrence risk point (TRRl+n) according to Peters [6, 7]
Risk group
Treatment outcome Gr. I (N=39) Gr. II (N=101) Gr. III (N=68) Gr. IV (N=10) P
1 – 4 points 5 – 9 points 10 – 14 points 15 – 20 points value
Local control (>5 yrs.) 24 – 62% 31 – 31% 11 – 56% 4 – 40% 0.00001
Local failure 0 – 0% 6 – 6% 9 – 13% 3 – 20% 0.005
Local recurrence 9 – 23% 27 – 27% 21 – 31% 0 – 0% 0.05
Nodal recurrence 2 – 5% 11 – 11% 9 – 13% 2 – 20% 0.01
Distant metastases 4 – 10% 23 – 23% 14 – 21% 1 – 10% 0.05
Uncertain data - 3 – 2% 4 – 6% -
Failure overall 15 – 38% 67 – 66% 53 – 78% 6 – 60% 0.0001
Tab. IV. Failure type and rate depending on treatment methods
Treatment methods No. pts. Local Nodal Distant Failure
recur. recur. meta. overall
A. Surg. alone 8 1 – 13% 0 – 0% 3 – 37% (1) 3 – 37%
B. Surg. – RT 143 29 – 20% 11 – 8% 18 – 13% (5) 53 – 37%
C. Surg. – rec. – RT 14 3 – 21% 2 – 14% 4 – 29% (3) 6 – 43%
D. Surg.- rec. – surg. – RT 6 2 – 30% 1 – 17% 1 – 17% 4 – 67%
E. Surg. – RT. 47 23 – 49% 10 – 21% 16 – 34% (7) 4 – 89%
Significance p <0.0001 p <0.001 p <0.0005 p <0.0001
Overall 218 57 – 26% 24 – 11% 42- 19% 108 – 50%
Aa (16 -7%)
() – No. of cases with distant meta together with local recurrence
Preoperative radiotherapy (RT – SG) is aimed to con-
trol subclinical disease with the wide region of primary le-
sion and to produce tumour regression in order to incre-
ase a chance of radical surgery [1].
The present results showed however that the RT –
SG treatment is less effective than surgery combined with
postoperative radiotherapy (SG – RT) and the respective
5-year DFS were 30% and 39%. This rates decreased to
only 20% when postoperative RT was delayed. Lower ef-
ficacy of the RT – SG was the result of higher incidence of
loco-regional recurrence (49% vs. 20%) and about 3-fold
difference in the incidence of distant metastases (34%
vs. 13%) than for the SG – RT combination. This observa-
tions are supported by other authors [8, 12-15]. Similar
tendency was observed by Regine et al. [16] who has no-
ted 44% 5-year DFS after radical surgery. After combina-
tion of SG – RT the incidence of local recurrence decre-
ased by 59%, and nodal recurrence and distant metastases
by 62% compared with RT – SG. Strong [15] also docu-
mented higher efficacy of SG – RT than radiotherapy
alone for both primary tumour and regional nodes with
50% reduction in recurrence rate if one neck level has be-
en involved.
Present results likely suggest that in combination SG
– RT surgery plays the major role. Furthermore microsco-
pically radical operation may significantly decrease the
risk of distant metastases and consequently leads to 20%
improvement in the distant meta free survival compared
with non-radical surgery. This gain was even higher if tu-
mour stage was accounted for (82% 5-year DMFS for
T1 compared with 58% for T2). Johnson et al. [17] also
observed better results for radical surgery combined with
postoperative RT. In the study of Zalefsky et al. [18] SG –
RT for oral cavity cancer produced 50% 5-year DFS. Al-
so Fletcher [19] has documented that radical SG – RT
decreased local recurrence risk by about 50% and do-
ubled 2-year survival rate.
There are only a few clinical prognostic factors which
can be considered before treatment (localisation, stage,
grade, growth kinetics). Majority of the most important
factors are established intra- or postoperatively. Surgical
margins are most often discussed as a major predictive
factor for postoperative RT. Many authors point out that
negative margins correlate with the reduction of recurren-
ce risk after SG – RT by about 27-30%. The present re-
sults support these observations. Negative margins lead
to 2-fold higher (58%) 5-year DFS than in the case of
positive margins. Critical argument is that histological
status of surgical margins is not a single and the most
important prognostic factor and it seems better to consi-
der a combination of factors than each one factor separa-
tely. In contrast to many authors who consider histolo-
gical margins as important prognostic factor and pre-
dictor for postoperative RT, Peters et al. [6] have focused
on extracapsular extension, documenting it as a major,
independent and significant predictor for postoperative
RT. Wang et al. [14] postulate however that N0 status
correlates with 88% local control after SG – RT whereas
more than 3 positive nodes in surgical specimen caused
the decrease of local control to 49%. Bartelink and
Cachin [1, 12] also support prognostic value of positive
neck nodes.
Parsons and Peters [6, 7, 13] were the first who pro-
posed, so called, „total package time” which in the present
paper is considered as total combined treatment time
(TTT). Present analysis supports the conclusion of these
authors that shortening the TI and OTT, and consequen-
tly the TTT would improve therapeutic gain of combi-
ned SG – RT. Parsons et al. [13] pointed out that it plays
an important role especially in the case of more than 4
unfavourable prognostic factors. The TTT shorter than 90
days has corresponded with 60% chance of long-term lo-
cal control, whereas for TTT longer than 100 days this
chance decreased to only 14%. Peters et al. [6, 7] have
proposed to begin postoperative radiotherapy as soon as
possible even directly after wound healing. Present re-
sults closely correspond with these suggestions and the
most significant impact of the TTT on treatment outcome
was noted in the group with high risk of local recurrence
(>10 points TRRl+n).
If a total „package time” has been checked as a clini-
cally useful concept it seems that a „total risk factor pac-
kage” could also be more practically convenient that each
one factor considered separately. The present results sup-
port this suggestion. Among all individual factors the
TRRl+n being the sum of rank values given to this fac-
tors has the highest, independent and significant progno-
stic power. For low risk group (TRRl+n <4 points) 5-
-year DFS was 62% and decreased to 19% for
TRRl+n of more than 10 points which makes on average
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Figure 4. Actuarial disease -free survival depending on: (A) Group of the recurrence risk, (B) TRRl+n value
3% decrease in DFS for each one point increase of
TRRl+n. Own results are similar to these published by
Peters although he has considered local tumour and node
recurrence risk separately.
Present results allow to propose the following algori-
thm for combined SG – RT treatment for patients with
cancer of oral cavity and oropharynx:
1. The choice of optimal combined treatment and its se-
quence for patients with head and neck cancer sho-
uld be decided by the team of surgeon, pathologist,
radiodiagnost and radiation oncologist before the start
of treatment.
2. To predict the highest possible therapeutic gain of com-
bined treatment it is important to estimate total risk
points (TRRl+n) including all clinical, biological, sur-
gical and pathological factors.
3. The TRRl+n equal zero (negative margins, no more
than 1-2 positive neck nodes in the level close to prima-
ry lesion without extracapsular extension) allows to
resign of radiotherapy after surgery, especially for el-
derly patients with long anamnesis.
4. For low recurrence risk (TRRl+n = 1 – 9 points) sur-
gery should be combined with postoperative conventio-
nal radiotherapy within 10 weeks.
5. High recurrence risk (TRRl+n > 10 points) call for po-
stoperative radiotherapy with short interval between
surgery and RT and shorten overall treatment time
(modified dose fractionation).
6. For borderline criteria to surgery it is important to
consider preoperative radiotherapy, however as short
as possible with immediate surgical treatment. Depen-
ding on the TRRl+n value postoperative RT should al-
so be considered (sandwich therapy).
7. Surgery alone and „wait and see” policy with radio-
therapy delayed until local recurrence occurred signi-
ficantly decreases long-term disease-free survival.
Conclusions
For patients with advanced cancer of the oral cavity or
oropharynx microscopically radical surgery combined
with postoperative radiotherapy is highly effective treat-
ment strategy providing on average 60% 5-year disease-
-free survival independent on TNM stage prior to treat-
ment, 20% decrease in the risk of distant metastases and
low (4%) risk of late complications.
Among well recognised positive prognostic factors at
least 5 mm negative surgical margins, no extracapsular
and vessel invasion, overall combined treatment time not
longer than 9 weeks are the most favourable. However it
is almost impossible to establish their hierarchy which
may change depending on tumour and patient characteri-
stics, surgeon experience and type of operation.
It seems clinically useful to replace individual factors
by one numerical value of total recurrence risk point
(TRRl+n) which reflect the number and prognostic po-
wer of unfavourable factors. The TRRl+n might be an
important guideline for postoperative radiotherapy and its
modifications if needed. Practical applicability of the
TRRl+n scale should be checked in prospective study.
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